As the global economy recovers in 2021 and the supply of the industrial chain improves, the Drug Formulation market will undergo major changes. The sales of the drug formulations market is estimated to reach a valuation of US$ 1.58 Tn by 2022. According to the study, oral formulations projects to grow exponentially with a CAGR of 6.0% during the forecast period.

The global Drug Formulation industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Drug Formulation market during the next few years. The global Drug Formulation market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Drug Formulation market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America

Player list
AstraZeneca plc.
Bristol-Myers Squibb
Eli Lilly and Company
Gilead Sciences, Inc.
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
AbbVie Inc.
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche AG
Johnson & Johnson
3M Company
Bayer AG
Teva Pharmaceuticals Industries Ltd.
Amgen, Inc.
Sanofi SA
GlaxoSmithKline plc
Boston Scientific Corporation
Gerresheimer AG

Types list
Solutions
Suspensions
Emulsions for injection or infusion
Powders for injection or infusion
Gels for injection implants

Application list
Big pharma
Small & Medium Size Pharma
Biotech Companies